Literature DB >> 11971976

Cell cycle arrest and apoptosis induced by human Polo-like kinase 3 is mediated through perturbation of microtubule integrity.

Qi Wang1, Suqing Xie, Jie Chen, Kenji Fukasawa, Ulhas Naik, Frank Traganos, Zbigniew Darzynkiewicz, Meena Jhanwar-Uniyal, Wei Dai.   

Abstract

Human Polo-like kinase 3 (Plk3, previously termed Prk or Fnk) is involved in regulation of cell cycle progression through the M phase (B. Ouyang, H. Pan, L. Lu, J. Li, P. Stambrook, B. Li, and W. Dai, J. Biol. Chem. 272:28646-28651, 1997). Here we report that in most interphase cells endogenous Plk3 was predominantly localized around the nuclear membrane. Double labeling with Plk3 and gamma-tubulin, the latter a major component of pericentriole materials, revealed that Plk3 was closely associated with centrosomes and that its localization to centrosomes was dependent on the integrity of microtubules. Throughout mitosis, Plk3 appeared to be localized to mitotic apparatus such as spindle poles and mitotic spindles. During telophase, a significant amount of Plk3 was also detected in the midbody. Ectopic expression of Plk3 mutants dramatically changed cell morphology primarily due to their effects on microtubule dynamics. Expression of a constitutively active Plk3 (Plk3-A) resulted in rapid cell shrinkage, which led to formation of cells with an elongated, unsevered, and taxol-sensitive midbody. In contrast, cells expressing a kinase-defective Plk3 (Plk3(K52R)) mutant exhibited extended, deformed cytoplasmic structures, the phenotype of which was somewhat refractory to taxol treatment. Expression of both Plk3-A and Plk3(K52R) induced apparent G(2)/M arrest followed by apoptosis, although the kinase-defective mutant was less effective. Taken together, our studies strongly suggest that Plk3 plays an important role in the regulation of microtubule dynamics and centrosomal function in the cell and that deregulated expression of Plk3 results in cell cycle arrest and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11971976      PMCID: PMC133784          DOI: 10.1128/MCB.22.10.3450-3459.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  32 in total

1.  Microtubule binding of the drosophila DMAP-85 protein is regulated by phosphorylation in vitro.

Authors:  V Cambiazo; E Logarinho; H Pottstock; C E Sunkel
Journal:  FEBS Lett       Date:  2000-10-13       Impact factor: 4.124

2.  A conserved mitotic kinase active at late anaphase-telophase in syncytial Drosophila embryos.

Authors:  B Fenton; D M Glover
Journal:  Nature       Date:  1993-06-17       Impact factor: 49.962

3.  Prk, a cytokine-inducible human protein serine/threonine kinase whose expression appears to be down-regulated in lung carcinomas.

Authors:  B Li; B Ouyang; H Pan; P T Reissmann; D J Slamon; R Arceci; L Lu; W Dai
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

4.  A multicopy suppressor gene of the Saccharomyces cerevisiae G1 cell cycle mutant gene dbf4 encodes a protein kinase and is identified as CDC5.

Authors:  K Kitada; A L Johnson; L H Johnston; A Sugino
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

5.  Identification by targeted differential display of an immediate early gene encoding a putative serine/threonine kinase.

Authors:  P J Donohue; G F Alberts; Y Guo; J A Winkles
Journal:  J Biol Chem       Date:  1995-04-28       Impact factor: 5.157

6.  Identification of an early-growth-response gene encoding a novel putative protein kinase.

Authors:  D L Simmons; B G Neel; R Stevens; G Evett; R L Erikson
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

7.  Polo-like kinase is a cell cycle-regulated kinase activated during mitosis.

Authors:  R Hamanaka; M R Smith; P M O'Connor; S Maloid; K Mihalic; J L Spivak; D L Longo; D K Ferris
Journal:  J Biol Chem       Date:  1995-09-08       Impact factor: 5.157

8.  The mitotic roles of Polo-like kinase.

Authors:  M M Donaldson; A A Tavares; I M Hagan; E A Nigg; D M Glover
Journal:  J Cell Sci       Date:  2001-07       Impact factor: 5.285

9.  Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5.

Authors:  R M Golsteyn; S J Schultz; J Bartek; A Ziemiecki; T Ried; E A Nigg
Journal:  J Cell Sci       Date:  1994-06       Impact factor: 5.285

10.  Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function.

Authors:  R M Golsteyn; K E Mundt; A M Fry; E A Nigg
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539

View more
  51 in total

1.  Effect of hypoxic stress-activated Polo-like kinase 3 on corneal epithelial wound healing.

Authors:  Jiawei Lu; Ling Wang; Wei Dai; Luo Lu
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-26       Impact factor: 4.799

2.  SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing.

Authors:  Jun Li; Mingjia Tan; Ling Li; Deepika Pamarthy; Theodore S Lawrence; Yi Sun
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

3.  Hyperosmotic stress-induced ATF-2 activation through Polo-like kinase 3 in human corneal epithelial cells.

Authors:  Ling Wang; Reid Payton; Wei Dai; Luo Lu
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

4.  BubR1 deficiency results in enhanced activation of MEK and ERKs upon microtubule stresses.

Authors:  Y L Yang; Q Duan; T B Guo; X X Wang; Q Ruan; G T Xu; J W Zhang; Z Y Lu; M Xu; L Lu; W Dai
Journal:  Cell Prolif       Date:  2007-06       Impact factor: 6.831

5.  Plk3 interacts with and specifically phosphorylates VRK1 in Ser342, a downstream target in a pathway that induces Golgi fragmentation.

Authors:  Inmaculada López-Sánchez; Marta Sanz-García; Pedro A Lazo
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

6.  Calcium-dependent inhibition of polo-like kinase 3 activity by CIB1 in breast cancer cells.

Authors:  Meghna U Naik; Ngoc T Pham; Kristin Beebe; Wei Dai; Ulhas P Naik
Journal:  Int J Cancer       Date:  2011-02-01       Impact factor: 7.396

7.  Role of Plk2 (Snk) in mouse development and cell proliferation.

Authors:  Sheng Ma; Jean Charron; Raymond L Erikson
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

Review 8.  The role of Plk3 in oncogenesis.

Authors:  C Helmke; S Becker; K Strebhardt
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

9.  Targeting subcellular localization through the polo-box domain: non-ATP competitive inhibitors recapitulate a PLK1 phenotype.

Authors:  Campbell McInnes; Kara Estes; Merissa Baxter; Zhengguan Yang; Doaa Boshra Farag; Paul Johnston; John S Lazo; Jianjun Wang; Michael D Wyatt
Journal:  Mol Cancer Ther       Date:  2012-07-30       Impact factor: 6.261

10.  Stimulation of polo-like kinase 3 mRNA decay by tristetraprolin.

Authors:  Thierry J Horner; Wi S Lai; Deborah J Stumpo; Perry J Blackshear
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.